BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2022 1:27:24 AM | Browse: 458 | Download: 1327
 |
Received |
|
2022-02-01 04:58 |
|
Peer-Review Started |
|
2022-02-01 04:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-17 08:04 |
|
Revised |
|
2022-04-29 15:55 |
|
Second Decision |
|
2022-06-01 02:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-03 21:34 |
|
Articles in Press |
|
2022-06-03 21:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-02 07:41 |
|
Publish the Manuscript Online |
|
2022-07-13 01:27 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kazuhisa Takeda, Yu Sawada, Yasuhiro Yabushita, Yuki Honma, Takafumi Kumamoto, Jun Watanabe, Ryusei Matsuyama, Chikara Kunisaki, Toshihiro Misumi and Itaru Endo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kazuhisa Takeda, PhD, Assistant Professor, Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan. kazu1968@yokohama-cu.ac.jp |
| Key Words |
Colorectal neoplasms; Neoadjuvant therapy; Neoplasm metastasis; Prognosis; Risk factors; Survival |
| Core Tip |
Hepatectomy is the mainstay of treatment for patients with colorectal liver metastases (CRLMs). However, there are cases of early recurrence after upfront hepatectomy alone. In selected high-risk patients, neoadjuvant chemotherapy (NAC) may improve long-term survival. Although several studies have identified risk factors for recurrence and prognosis after hepatectomy for CRLMs, they could not show a benefit of NAC for resectable CRLMs. This article demonstrated the effectiveness of NAC for initially resectable CRLMs, based on risk stratification according to prognostic factors. |
| Publish Date |
2022-07-13 01:27 |
| Citation |
Takeda K, Sawada Y, Yabushita Y, Honma Y, Kumamoto T, Watanabe J, Matsuyama R, Kunisaki C, Misumi T, Endo I. Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study. World J Gastrointest Oncol 2022; 14(7): 1281-1294 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i7/1281.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i7.1281 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
